VALYSTR · Stock research
Listed on NasdaqGS. What the market is pricing into Biogen Inc. (BIIB) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Drug Manufacturers - General · market value about $36.8B · P/E 106.5 · revenue $10.3B (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows